🔎 Trials Near Me

Akèy › Gliyoblastòm › Tennessee › Nashville

Etid klinik pou Gliyoblastòm nan Nashville, TN

9 etid pou Gliyoblastòm ap chèche patisipan nan sit nan ak bò kote Nashville (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Ap rekriteFaz 1/2
  • Vanderbilt University Medical Center, Nashville
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT06047379

A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors

Ap rekriteFaz 1/2
  • SCRI Oncology Partners, Nashville
Laj 18 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT06914128

Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma

Ap rekriteFaz 1
  • Vanderbilt University/Ingram Cancer Center, Nashville
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT06860594

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

Ap rekriteFaz 3
  • Vanderbilt-Ingram Cancer Center, Nashville
Laj 18 ak plis · Tout sèks · Mizajou Aug 28, 2026 · NCT05303519

DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)

Ap rekriteFaz 2
  • Vanderbilt-Ingram Cancer Center, Nashville
Laj 18 ak plis · Tout sèks · Mizajou Jul 1, 2026 · NCT06805305

Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures

Ap rekriteFaz 1 bonè
  • Vanderbilt University Medical Center, Nashville
Laj 18 ak plis · Tout sèks · Mizajou Jun 30, 2026 · NCT07493447

A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies

Ap rekriteFaz 1
  • Sarah Cannon, SCRI Oncology Partners, Nashville
Laj 18 ak plis · Tout sèks · Mizajou Jun 23, 2026 · NCT04678648

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Ap rekriteEtid obsèvasyon
  • Massive Bio SYNERGY-AI site, Nashville
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors

Ap rekriteFaz 1/2
  • Tennessee Oncology, Nashville
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2025 · NCT05941507

Etid Gliyoblastòm nan lòt vil

Lòt etid nan Nashville

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.